As shown in Supplementary Fig. 2e, TxNIP expression increased as pathological grades increased, with the expression being significantly higher in grade IV than in grade I gliomas (P = 0.001), but no difference was noted between grade I and III (P = 0.556) or between grade III and IV gliomas (P = 0.052). Here, TXNIP is linked to central nervous system cancer.